| Financial Year |
March 31 2023 |
| Monetary Funds |
3,395,797,365.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
28,825,799.54 |
| Accounts Receivable |
847,020,412.18 |
| Advances to Suppliers |
147,130,378.83 |
| Other Receivables |
60,485,049.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,163,526,852.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
40,574,125.36 |
| Total Current Assets |
5,937,204,933.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
87,993,476.70 |
| Investment Properties |
9,894,088.18 |
| Fixed Assetes |
539,340,294.50 |
| Under-construction Projects |
117,369,853.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,255,411.46 |
| R&D expenses |
-- |
| Goodwill |
220,858,702.66 |
| Long-Term Deferred and Prepaid Expenses |
11,237,871.74 |
| Deferred Income Tax Assets |
12,371,246.66 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,087,230,047.27 |
| Total Assets |
7,024,434,980.85 |
| Short-Term Loans |
8,015,489.74 |
| Trading Financial liabilities |
-- |
| Notes Payable |
117,223,722.63 |
| Accounts Payable |
815,560,413.17 |
| Accounts Received In Advance |
4,556,772.17 |
| Employee Compensation Payable |
32,852,887.00 |
| Taxes Payable |
32,639,104.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
172,566,589.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,680,759.42 |
| Other Current Liabilities |
17,466,866.41 |
| Sub-Total of Current Liabilities |
1,999,903,592.94 |
| Long-term Loans |
174,641,104.04 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
11,615,584.78 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
252,559,594.53 |
| Total Liabilities |
2,252,463,187.47 |
| Paid-In Capital(Or Share Stock) |
1,367,673,455.00 |
| Capital Surplus |
1,487,686,560.59 |
| Surplus Reserve |
409,308,804.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,326,067,854.27 |
| Minority Stockholder's Interest |
181,144,186.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,590,827,607.36 |
| Owner's Equity（Stockholder's Equity） |
4,771,971,793.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,024,434,980.85 |
